Extralehdet Extralehdet
Novo Nordisk A/S and Eli Lilly & Co. shares fell after President Donald Trump said the price of the blockbuster diabetes drug Ozempic could come down to just $150 a month.
Latest posts by Toimitus (see all)
Novo, Lilly Fall as Trump Touts ‘Much Lower’ Ozempic Price
